跳至主要内容
临床试验/JPRN-UMIN000003226
JPRN-UMIN000003226已完成未知

Effects of risedronate on the progression of aortic valv stenosis in osteoporosis patients - ROTAS(Risedronate and Osteoporosis Therapy in Aortic valve Stenosis)

Juntendo University School of Medcine, The department of Cardiology0 个研究点目标入组 180 人开始时间: 2010年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.rheumatic mitral valve disease 2.patients receiving treatment with oral bisphosphonates 3.congestive heart failure 4.bicuspid aortic valve 5.renal failure(eGFR<30) 6.hepatic dysfunction 7.mild aortic regurgitation, and previous aortic valve surgery 8.patients with hormone recruitment therapy 9.not suitable to this study based upon doctor's judge 10.Abnormalities of the esophagus such a achalasia 11.Known hypersensitivity to any component of this product 12.Hypocalcemia 13.Inability to stand or sit upright for at least 30 minutes after taking the medication 14.patients requiring dental treatment or within 2 month after dental treatment 15.active gastric and duodenal ulcers

研究者

发起方
Juntendo University School of Medcine, The department of Cardiology

相似试验